CTOs on the Move

GI Pathology PLLC

www.gipath.com

 
GI Pathology PLLC is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Memphis, TN. To find more information about GI Pathology PLLC, please visit www.gipath.com
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.gipath.com
  • 150 Collins St
    Memphis, TN USA 38112-3814
  • Phone: 901.526.7444

Executives

Name Title Contact Details

Similar Companies

Unlock Health

Unlock Health Chiropractic is a natural medical service provider that offers long term solutions and overall wellness for families.

Pharmacy Access Solutions

Pharmacy Access Solutions Inc. is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Massive Bio

Increasing Accessibility to Clinical Trials and Personalized Cancer Treatment Options. Every cancer patient is different and deserves treatment of the highest quality that is personalized, affordable, and easily accessible. Massive Bio translates the world-class oncology knowledge of the large cancer centers​ experts, facilitates a virtual tumor board collaboratively with the treating oncologist, and advises the patient and treating oncologist to operationalize these expert recommendations at the point of care thereby, eliminating additional time, travel, and cost. 85% of US cancer patients receive treatments in community practices where treating oncologists are overwhelmed with the influx of new tests and treatments while trying to manage their busy practices. We believe all cancer patients deserve equal access to the latest in cancer research and treatment.

Quality Home Health Care

Quality Home Health Care is a Sanford, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Diagnocure

DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.